Premium
P4‐104: HSV‐1 Avidity Index: A Possible Biomarker for Monitoring the Evolution of Mild Cognitive Impairment to Alzheimer’s Disease
Author(s) -
Agostini Simone,
Mancuso Roberta,
Calabrese Elena,
Hernis Ambra,
Nemni Raffaello,
Clerici Mario
Publication year - 2016
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2016.06.2195
Subject(s) - avidity , dementia , disease , medicine , herpes simplex virus , biomarker , pathogenesis , pathological , atrophy , immunology , cognition , antibody , oncology , virus , psychiatry , biology , biochemistry
pram. Furthermore, SI reduced the levels of BDNF, serine473-phosphorylated Akt (active form) and serine-9-phosphorylated GSK-3b (inactive form) with no significant changes in the levels of total GSK-3b and Akt in the dorsal hippocampus, but not in the posterior cingulate. Conclusions:Our results suggest that decreased synaptic plasticity in cognition-associated regions might contribute to SI-induced cognitive deficits, and citalopram could ameliorate these deficits by promoting synaptic plasticity mainly in the prefrontal cortex, dorsal hippocampus and ventral hippocampus. The BDNF/Akt/GSK-3b pathway plays an important role in regulating synaptic plasticity in SI rats.